🇺🇸 FDA
Pipeline program

ISIS-APO(a)Rx

ISIS 494372-CS3

Phase 2 small_molecule completed

Quick answer

ISIS-APO(a)Rx for Elevated Lipoprotein(a) is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Elevated Lipoprotein(a)
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials